Showing 1 to 10 of 87 clinical trials
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 |
|
CLINICAL TRIALS Trial No ClinicalTrials.gov ID |
Phase | Coordinator | |
|---|---|---|---|
|
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-high-risk Neuroblastoma
COG-ANBL-1232 NCT02176967  Recruiting
|
CENTRE HOSPITALIER UNIVERSITAIRE SAINTE-JUSTINE |
Phase III |
Martine Therrien 514-345-4931 poste 3396 |
|
A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients With Germ Cell Tumors
COG-AGCT1531 NCT03067181 Recruiting
|
CENTRE HOSPITALIER UNIVERSITAIRE SAINTE-JUSTINE |
Phase III |
Martine Therrien 514-345-4931 poste 3396 |
|
International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Testing Imatinib in Combination With Two Different Cytotoxic Chemotherapy Backbones
COG-AALL1631 NCT03007147 Recruiting
|
CENTRE HOSPITALIER UNIVERSITAIRE SAINTE-JUSTINE |
Phase III |
Clemence Noury 514-345-4931 poste 6848 |
|
LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis
LCH-IV NCT02205762 Recruiting
|
CENTRE HOSPITALIER UNIVERSITAIRE SAINTE-JUSTINE |
Phase II |
Maud Frizot 514-345-4931 poste 5467 |
|
A Phase 2 Study of the JAK1/JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High-Risk CRLF2-Rearranged and/or JAK Pathway-Mutant Acute Lymphoblastic Leukemia
COG-AALL1521 NCT02723994 Recruiting
|
CENTRE HOSPITALIER UNIVERSITAIRE SAINTE-JUSTINE |
Phase II |
Clemence Noury 514-345-4931 poste 6848 |
|
A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma
SJMB12 NCT01878617 Recruiting
|
CENTRE HOSPITALIER UNIVERSITAIRE SAINTE-JUSTINE |
Phase II |
Linda Hershon 514-345-4931 poste 5899 |
|
NMTT- Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine (DFMO)
NMTRC014 NCT02679144 Recruiting
|
CENTRE HOSPITALIER UNIVERSITAIRE SAINTE-JUSTINE |
Phase II |
Martine Therrien 514-345-4931 poste 3396 |
|
A Phase 1 Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric Patients With Relapsed or Refractory Malignancies
M13-833 Venetoclax NCT03236857 Recruiting
|
CENTRE HOSPITALIER UNIVERSITAIRE SAINTE-JUSTINE |
Phase I |
Linda Hershon 514-345-4931 poste 5899 |
|
A Phase I and Enrichment Study of Low-dose Metronomic Topotecan and Pazopanib in Pediatric Patients With Recurrent or Refractory Solid Tumours Including CNS Tumours
IND.217 (TOPAZ) NCT02303028 Recruiting
|
CENTRE HOSPITALIER UNIVERSITAIRE SAINTE-JUSTINE |
Phase I |
Linda Hershon 514-345-4931 poste 5899 |
|
A Children's Oncology Group Protocol for Collecting and Banking Pediatric Research Specimens Including Rare Pediatric Tumors
COG-ABTR01B1 NCT00898079 Recruiting
|
CENTRE HOSPITALIER UNIVERSITAIRE SAINTE-JUSTINE |
Autres |
Martine Therrien 514-345-4931 poste 3396 |
Groupe d'étude en oncologie du Québec